Hims & Hers Health, Inc. (NYSE: HIMS) is a Healthcare company (Medical - Care Facilities) with a market capitalization of $4.4B. The Maz Rating grades it against the other companies in its sector.
About three months ago (July 2, 2026), Hims & Hers Health, Inc. had a Maz Rating of 2.30 out of 5 (C, Hold), ranked against the other companies in its sector. Its strongest factor then was Profitability (4.55), among the strongest in its sector; its weakest was Valuation (1.31), among the most expensive in its sector. The other factors: Momentum 3.30 (around the middle of its sector); Growth 2.59 (around the middle of its sector); Financial Health 1.46 (among the weakest in its sector). The current rating is for members: log in to see it.
At $19.73, Hims & Hers Health, Inc. trades at 1.6x sales and 13.7x book value. Over the last twelve months it generated about $2.7B of revenue and a net loss of $175M. It runs a gross margin of 60.5%, an operating margin of -5.9% and a net margin of -6.7%. It shows return on equity of -45.8%, return on invested capital of -6.9% and a free cash flow yield of 0.7%. On the balance sheet: a debt-to-equity ratio of 4.39 and a current ratio of 0.92. Over the past 52 weeks the share price ranged from $13.74 to $40.99, with a beta of 2.50.
Hims & Hers Health, Inc. does not currently pay a dividend.
20 Wall Street analyst ratings cover the stock: 7 Buy and 13 Hold, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.